H.W. Eijkhout

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital

A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage

Practice parameter for the diagnosis and management of primary immunodeficiency

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

Octagam® 5%, an Intravenous IgG Product, Is Efficacious and Well Tolerated in Subjects with Primary Immunodeficiency Diseases

Oral Anticoagulant Therapy

Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate

Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists

Graft-versus-host disease

Prothrombin complex concentrate (Octaplex®) in patients requiring immediate reversal of oral anticoagulation

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy

Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature

Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature

Protein therapeutics: a summary and pharmacological classification

Infections in 252 Patients with Common Variable Immunodeficiency

Zoonotic Potential and Molecular Epidemiology ofGiardiaSpecies and Giardiasis

2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines

Intravenous Immunoglobulin: Striving for Appropriate Use

Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Prothrombin Complex Concentrate Accelerates International Normalized Ratio Reversal and Diminishes the Extension of Intracranial Hemorrhage in Geriatric Trauma Patients

Prothrombin Complex Concentrate Versus Standard Therapies for INR Reversal in Trauma Patients Receiving Warfarin

Clinical Practice Guideline (Update): Adult Sinusitis

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: An open, prospective randomized controlled trial

The Effect of Two Different Dosages of Intravenous Immunoglobulin on the Incidence of Recurrent Infections in Patients with Primary Hypogammaglobulinemia

Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy.